Tissue Plasminogen Activator (tPA) is a protein involved in the breakdown of blood clots, often used as a medication to treat acute ischemic stroke by helping to restore blood flow to the affected brain region. It works by converting plasminogen to plasmin, the enzyme responsible for clot dissolution, but must be administered within a short window of time after stroke onset to be effective and minimize potential side effects such as bleeding.